Silexion Therapeutics (NASDAQ:SLXN) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Silexion Therapeutics (SLXN) operate in?

Silexion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Silexion Therapeutics Stock (NASDAQ: SLXN) stock price, news, charts, stock research, profile.

Open	$0.27
Close	$0.32
Volume / Avg.	5.98M / 5.74M
Day Range	$0.24 - $0.33
52 Wk Range	0.21 - 4.65
Market Cap	$4.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	7.33%
Days to Cover	1

Recent News

What's Going On With Silexion Therapeutics Shares Wednesday?

Silexion Therapeutics shares are moving higher on Wednesday after the company reported that Guangzhou Sino-Israel bio-industry investment fund holds a decent stake in the company.

Dylan Berman

US Stocks Mostly Lower; Target Posts Downbeat Earnings

Avi Kapoor

Silexion Investigational Pancreatic Cancer Treatment Shows Promise In Animal Studies

Silexion Therapeutics' stock surged after the company revealed preclinical findings for SIL-204, its siRNA candidate.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.27
Close	$0.32
Volume / Avg.	5.98M / 5.74M
Day Range	$0.24 - $0.33
52 Wk Range	0.21 - 4.65
Market Cap	$4.06M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	7.33%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Silexion Therapeutics (SLXN) stock?

You can purchase shares of Silexion Therapeutics (NASDAQ:SLXN) through any online brokerage.

View our list of the best stock brokerages

Who are Silexion Therapeutics (SLXN) competitors?

Other companies in Silexion Therapeutics’s space includes: Alzamend Neuro (NASDAQ:ALZN), Tharimmune (NASDAQ:THAR), Palisade Bio (NASDAQ:PALI), Portage Biotech (NASDAQ:PRTG) and Viracta Therapeutics (NASDAQ:VIRX).

What is the forecast, or price target, for Silexion Therapeutics (SLXN) stock?

Silexion Therapeutics has a consensus price target of $1.00.

What is the current price for Silexion Therapeutics (SLXN)?

The stock price for Silexion Therapeutics (NASDAQ: SLXN) is $0.2815 last updated November 21, 2024 at 7:59 PM EST.

Does Silexion Therapeutics (SLXN) pay a dividend?

There are no upcoming dividends for Silexion Therapeutics.

When is Silexion Therapeutics (NASDAQ:SLXN) reporting earnings?

Silexion Therapeutics’s Q4 earnings are confirmed for Friday, February 21, 2025.

Is Silexion Therapeutics (SLXN) going to split?

There is no upcoming split for Silexion Therapeutics.

What sector and industry does Silexion Therapeutics (SLXN) operate in?

Silexion Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Silexion Therapeutics

Silexion Therapeutics (SLXN) Forecast